Prof. Dr. Halil Taşkaynatan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 8 publicationsSource: OpenAlex / PubMed MeSHView publications
- Pancreatic Neoplasms 3 publications
- Neoplasms 3 publications
- Stomach Neoplasms 2 publications
- Colorectal Neoplasms 2 publications
- Lung Neoplasms 2 publications
- Carcinoma, Ovarian Epithelial 2 publications
- Neoplasms, Glandular and Epithelial 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
- Area of workBreast NeoplasmsExtracted from 8 publications · Model version —From source
- Publications62 publicationsOpenAlex, ORCID, Europe PMCFrom source
- ORCID0000-0002-3671-6540ORCIDFrom source
- Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046789/doktorlarimiz.html#halil-taskaynatansaglik.gov.tr
Scientific work
Publications on Breast Neoplasms
-
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15103979 PMID 42194940 Open-access full textSource: OpenAlex
-
The RATAB Framework: An Interpretable AI-Driven Radiographic Risk Stratification Model for Suspected Lung Lesions
Journal of Imaging Informatics in Medicine, 2026
DOI 10.1007/s10278-026-02303-5 PMID 42768277 Source: OpenAlex
-
KIM-1 immunohistochemistry and early ccRCC recurrence outside adjuvant eligibility criteria: a two-centre exploratory study
BMC Cancer, 2026
DOI 10.1186/s12885-026-17191-9 Open-access full textSource: OpenAlex
-
Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma
Tumori Journal, 2026
DOI 10.1177/03008916251410475 PMID 41568754 Source: ORCID
-
Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study
Cancers, 2026
DOI 10.3390/cancers18203329 PMID 42938863 Open-access full textSource: ORCID
-
Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
Diagnostics, 2026
DOI 10.3390/diagnostics16091277 PMID 42121981 Open-access full textSource: ORCID
-
Association of Abdominal Aortic Calcification with Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Retrospective Exploratory Study
Asian Pacific journal of cancer prevention : APJCP, 2026
DOI 10.31557/apjcp.2026.27.10.3723 PMID 42935064 Open-access full textSource: Europe PMC
-
Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer
BMC Medical Imaging, 2026
DOI 10.1186/s12880-026-02463-4 PMID 42185986 Open-access full textSource: OpenAlex
-
Pretreatment Hemoglobin, Albumin, Lymphocyte, and Platelet Score Predicts Pathological Response and Postoperative Pathological Findings in Locally Advanced Gastric Cancer
Journal of Oncological Sciences, 2026
DOI 10.37047/jos.galenos.2026.2026-5-2 Open-access full textSource: OpenAlex
-
Cumulative chemotherapy exposure and social isolation as correlates of caregiver burden and anxiety among family caregivers in outpatient oncology: a cross-sectional study
Research Square, 2026
DOI 10.21203/rs.3.rs-11062964/v1 Open-access full textSource: OpenAlex